Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease

Neurobiology of Disease(2021)10.1016/j.nbd.2021.105478Source: DataRank Database

Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease is a research paper published in Neurobiology of Disease (2021). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.18)OA: goldTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Miloš Stanojlović ORCID,Moriel Zelikowsky ORCID,Jana Bonsberger ORCID,Sindalana Hean,Caitlin Mulligan ORCID

Live enrichment

PubMed:34390837 PMC:PMC8447919 OpenAlex:https://openalex.org/W3194492754

NINDS NIH HHS

Grant: P50 NS038367

NIMH NIH HHS

Grant: R01 MH132822

NIMH NIH HHS

Grant: R00 MH108734

FWCI

2.18

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.nbd.2021.105478

publisherhttps://doi.org/10.1016/j.nbd.2021.105478

publisherhttps://api.elsevier.com/content/article/PII:S0969996121002278?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0969996121002278?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34390837

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsAlzheimer's disease research and treatments

MeSH Terms

SynucleinopathiesAmygdalaAnimalsExtinction, PsychologicalFearGliosisHumansMaleMice, Inbred C57BLMice, TransgenicNeuronsParkinson DiseaseParvalbuminsPhosphorylationMicealpha-Synuclein

Keywords

AmygdalaNeurosciencePsychologyAlpha-synucleinSubstantia nigraExtinction (optical mineralogy)ParvalbuminParkinson's diseaseDopaminergicDopaminePathologyMedicineDiseaseBiologyAnxietySynucleinopathyFear ConditioningLine 61

Sustainable Development Goals

SDG 0: Good health and well-being

Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease

FAIR Checklist

Authors (12)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)